Single cell study for relapsed or refractory acute myeloid leukemia
Treatments studied
Part of Blood & lymphatic, Cancer clinical trials.
This study looks at individual leukemia cells to better understand why the disease comes back or doesn't respond to treatment. It may help doctors find better ways to treat people with this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult (18 years or older).
- You have acute myeloid leukemia (AML) that has come back after treatment or has not responded to treatment.
- You have leukemia cells in your blood (circulating blasts).
- You are covered by a social security plan (like health insurance).
- You have received information about the study and do not object to participating.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects blood and bone marrow samples from patients with blood cancers to understand why treatments stop working. It aims to improve future treatments.
This study tests a personalized approach to treating acute myeloid leukemia (AML) that has come back or stopped responding to prior treatments. Researchers will analyze your leukemia cells in the lab to find the best drug combination for your specific cancer, with the goal of improving treatment outcomes.
This study checks for “minimal residual disease,” meaning tiny numbers of leukemia cells that can remain after treatment. Results may help doctors better monitor your response and risk of relapse in AML or high-risk MDS.
This study looks at how the immune system changes when acute myeloid leukemia (AML) comes back after a donor stem cell transplant. It may help researchers create more personalized treatment plans and future guidelines for how to care for people in this situation.
This trial looks at blood and bone marrow samples from children and teens whose leukemia has come back or is hard to treat. The goal is to better understand the disease and guide future options for these patients.
This study uses advanced tests (genetics and other 'omics' methods) to better understand your leukemia and find a treatment that targets its specific features. It may help if standard treatments haven't worked or stopped working.
Hear when a new Acute Myeloid Leucemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.